Shimizu, D.; Yuge, R.; Kitadai, Y.; Ariyoshi, M.; Miyamoto, R.; Hiyama, Y.; Takigawa, H.; Urabe, Y.; Oka, S.
Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts. Int. J. Mol. Sci. 2024, 25, 7001.
https://doi.org/10.3390/ijms25137001
AMA Style
Shimizu D, Yuge R, Kitadai Y, Ariyoshi M, Miyamoto R, Hiyama Y, Takigawa H, Urabe Y, Oka S.
Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts. International Journal of Molecular Sciences. 2024; 25(13):7001.
https://doi.org/10.3390/ijms25137001
Chicago/Turabian Style
Shimizu, Daisuke, Ryo Yuge, Yuki Kitadai, Misa Ariyoshi, Ryo Miyamoto, Yuichi Hiyama, Hidehiko Takigawa, Yuji Urabe, and Shiro Oka.
2024. "Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts" International Journal of Molecular Sciences 25, no. 13: 7001.
https://doi.org/10.3390/ijms25137001
APA Style
Shimizu, D., Yuge, R., Kitadai, Y., Ariyoshi, M., Miyamoto, R., Hiyama, Y., Takigawa, H., Urabe, Y., & Oka, S.
(2024). Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts. International Journal of Molecular Sciences, 25(13), 7001.
https://doi.org/10.3390/ijms25137001
